Stock analysts at Canaccord Genuity started coverage on shares of InterCure (OTCMKTS:IRCLF) in a report issued on Monday, The Fly reports. The brokerage set a “buy” rating on the stock.
InterCure stock opened at $6.50 on Monday. InterCure has a 1-year low of $2.01 and a 1-year high of $11.44.
Featured Story: Insider Trading
Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.